Background: The long-term efficacy of mesoatrial shunt (MAS) for Budd-Chiari syndrome (BCS) is not well studied. The purpose of our study was to investigate the long-term outcome and efficacy of MAS for BCS.
Methods: We retrospectively evaluated 11 patients who underwent MAS for BCS from April 1986 to November 1995. Records of patients' clinical presentations, laboratorial investigation, Doppler duplex ultrasonography, radiologic image, and treatment outcomes were all retrieved and analyzed.
Results: Follow-up intervals ranged from 1 year and 2 months to 30 years and 2 months (mean, 17 years and 8 months). Portal pressure decreased significantly from 35.72 ± 3.52 cm HO to 27.86 ± 5.83 cm HO post-MAS (P = 0.001). The 5-year, 10-year, and 20-year patency were 72.7%, 54.5%, 36.4%, respectively; 63.3% of patients had survived for more than 10 years and 45.5% for more than 20 years. A male has been alive with patent shunt for 28 years and 1 month.
Conclusions: The MAS with enforced rings is an effective therapeutic modality for BCS with cautious perioperative management.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.avsg.2017.07.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Is There Still a Role for Surgical Shunts in the Treatment of Budd-Chiari Syndrome? A 25-Year Experience.
J Gastrointest Surg
June 2020
HPB Surgery Unit, Department of General Surgery,Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Purpose: To investigate the long-term results of shunt surgery in the treatment of Budd-Chiari Syndrome.
Methods: Medical records of patients treated with Budd-Chiari Syndrome between 1993 and 2006 were reviewed.
Results: Thirty-seven patients (26 female, 11 male) were identified, with a median age of 30 years (range 14-51).
Mesoatrial Shunt for Budd-Chiari Syndrome.
Ann Vasc Surg
February 2018
Department of Cardiovascular Surgery, The General Hospital of the PLA Rocket Force, Beijing Normal University, Beijing, China.
Background: The long-term efficacy of mesoatrial shunt (MAS) for Budd-Chiari syndrome (BCS) is not well studied. The purpose of our study was to investigate the long-term outcome and efficacy of MAS for BCS.
Methods: We retrospectively evaluated 11 patients who underwent MAS for BCS from April 1986 to November 1995.
Budd-Chiari syndrome revisited: 38 years' experience with surgical portal decompression.
J Gastrointest Surg
February 2012
Department of Surgery, University of California San Diego Medical Center, 200 West Arbor Drive, San Diego, CA 92103-8999, USA.
Objective: Ten years ago, we reported our results with what remains as the largest clinical experience with surgical portal decompression for Budd-Chiari syndrome (BCS) in the West. Since then, our series has expanded to 77 patients, and there has been an explosion of interest in and publications about BCS. The objectives of this study are to assess the validity of our observations and conclusions regarding BCS reported 10 years ago by expansion of our series of patients and observations of outcomes over an additional decade of close follow-up.
View Article and Find Full Text PDFLiving donor liver transplantation in Budd-Chiari syndrome: a single-center experience.
Transplant Proc
April 2010
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Budd-Chiari syndrome (BCS), which is characterized by hepatic venous outflow obstruction due to occlusion of the major hepatic vein and/or the inferior vena cava (IVC), is rare. Traditionally, a caval resection is advocated for these patients; however, such a maneuver renders living donor liver transplantation (LDLT) impossible. We encountered BCS in 4/377 LDLT patients during a 5-year period (January 2003 to December 2007).
View Article and Find Full Text PDFLong-term follow-up study and comparison of meso-atrial shunts and meso-cavo-atrial shunts for treatment of combined Budd-Chiari syndrome.
J Surg Res
June 2011
Department of Hepatic-Biliary Surgery, Qilu Hospital, Shandong University, Ji'nan, China.
Background: To investigate therapeutic effects of meso-atrial shunts (MASs) and meso-cavo-atrial shunt (MCASs) in combined Budd-Chiari syndrome (BCS).
Methods: We retrospectively gathered 29 cases of combined BCS with all or bilateral hepatic vein occlusion and long range occlusion or obstruction of inferior vena cava (IVC). Of them, 12 were treated with a MAS and 17 with a MCAS.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!